academic article

• Estrogen receptor-beta is a potential target for triple negative breast cancer treatment..  Oncotarget.  9:33912-33930. 2018
• Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells..  Molecular cancer research : MCR.  10:1597-606. 2012